Clearstead Advisors’s Bausch Health BHC Stock Holding History

Clearstead Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,000	Closed	-$7.13K	–	2033
2024 Q1	$7.13K	Hold	1,000	–	–	﹤0.01%	1122
2023 Q4	$8.02K	Sell	1,000 -1,000	-50%	-$7.28K	﹤0.01%	1099
2023 Q3	$16.4K	Buy	2,000 +1,000	+100%	+$8.62K	﹤0.01%	1050
2023 Q2	$8K	Hold	1,000	–	–	﹤0.01%	1007
2023 Q1	$8.1K	Hold	1,000	–	–	﹤0.01%	977
2022 Q4	$6.28K	Hold	1,000	–	–	﹤0.01%	960
2022 Q3	$7K	Buy	+1,000	New	+$6.95K	﹤0.01%	927

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Clearstead Advisors's BHC Position: Q2 2024 in Review

Clearstead Advisors sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 1,000 shares — an estimated $7.13K sold.

Clearstead Advisors first reported a position in BHC in Q3 2022 and held it in 7 quarters. The position peaked at $16.4K in Q3 2023. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

Clearstead Advisors reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
Clearstead Advisors sold 1,000 Bausch Health shares in Q2 2024, an estimated $7.13K.
Clearstead Advisors first reported a position in Bausch Health in Q3 2022 and held it in 7 quarters.
Clearstead Advisors's Bausch Health position peaked at $16.4K in Q3 2023.
234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Clearstead Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.